PHOSPHATE THERAPEUTICS LTD.

07618820
Active Gateshead Quays

Research and experimental development on biotechnology

0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PHOSPHATE THERAPEUTICS LTD.

07618820

Research and experimental development on biotechnology

Founded 3 May 2011 Active Gateshead Quays, United Kingdom 0 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 10 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 7 Jul 2025 Next due 17 Jul 2026 28 days remaining
Net assets £-26K £691K 2023 year on year
Total assets £1K
Total Liabilities £27K £690K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Northern Design Centre Baltic Business Quarter Gateshead Quays Tyne And Wear NE8 3DF

Website

www.example.com

Full company profile for PHOSPHATE THERAPEUTICS LTD. (07618820), an active life sciences and medical technology company based in Gateshead Quays, United Kingdom. Incorporated 3 May 2011. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2023)

Cash in Bank

N/A

Net Assets

-£26.00k

Increased by £691.00k (+96%)

Total Liabilities

£27.00k

Decreased by £690.00k (-96%)

Turnover

N/A

Employees

N/A

Decreased by 3 (-100%)

Debt Ratio

2700%

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Mar 2012Unknown/Other
Investor 2Feb 2016Acquisition

Officers

Officers

1 active 2 resigned
Status
Lucy Kate Huntington-baileyDirectorBritishEngland3921 Apr 2020Active

Shareholders

Shareholders (1)

Shield Therapeutics Plc
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Group Structure

Group Structure

PHOSPHATE THERAPEUTICS LTD. Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
10 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
7 Jul 2025Confirmation StatementConfirmation statement made on 3 Jul 2025 with no updates
5 Aug 2024OfficersTermination of Gregory Paul Madison as director on 24 Jul 2024
12 Jul 2024AccountsAnnual accounts made up to 31 Dec 2023
3 Jul 2024Confirmation StatementConfirmation statement made on 3 Jul 2024 with no updates
10 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

7 Jul 2025 Confirmation Statement

Confirmation statement made on 3 Jul 2025 with no updates

5 Aug 2024 Officers

Termination of Gregory Paul Madison as director on 24 Jul 2024

12 Jul 2024 Accounts

Annual accounts made up to 31 Dec 2023

3 Jul 2024 Confirmation Statement

Confirmation statement made on 3 Jul 2024 with no updates

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

9 months ago on 10 Sept 2025

Confirmation statement made on 3 Jul 2025 with no updates

11 months ago on 7 Jul 2025

Termination of Gregory Paul Madison as director on 24 Jul 2024

1 years ago on 5 Aug 2024

Annual accounts made up to 31 Dec 2023

1 years ago on 12 Jul 2024

Confirmation statement made on 3 Jul 2024 with no updates

1 years ago on 3 Jul 2024